Weniger Migränetage und leichtere Attacken mit Eptinezumab
Crossref DOI link: https://doi.org/10.1007/s15005-023-3824-4
Published Online: 2024-01-29
Published Print: 2024-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Herrmann, Matthias
Text and Data Mining valid from 2024-01-01
Version of Record valid from 2024-01-01
Article History
First Online: 29 January 2024